AR048274A1 - Sintesis estereoselectiva de analogos de vitamina d - Google Patents
Sintesis estereoselectiva de analogos de vitamina dInfo
- Publication number
- AR048274A1 AR048274A1 ARP050101046A ARP050101046A AR048274A1 AR 048274 A1 AR048274 A1 AR 048274A1 AR P050101046 A ARP050101046 A AR P050101046A AR P050101046 A ARP050101046 A AR P050101046A AR 048274 A1 AR048274 A1 AR 048274A1
- Authority
- AR
- Argentina
- Prior art keywords
- general structure
- enriched
- mixture
- compounds
- defined above
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 2: Un método para producir calcipotriol o monohidrato de calcipotriol que comprende los pasos de (a)-(b) de la reivindicacion 1 y adicionalmente que comprende los pasos de: (f) isomerizar la mezcla de compuestos de estructura general Va y Vb, en donde R1 y R2 son segun lo definido anteriormente, la cual es enriquecida con Va, hasta una mezcla de compuestos de la estructura general VIa y VIb, la cual es enriquecida con VIa, en donde R1 y R2 son segun lo definido anteriormente; (g) separar opcionalmente el compuesto de estructura general VIa de la mezcla de compuestos de estructura general VIa y VIb la cual es enriquecida con VIa, en donde R1 y R2 son segun lo definido anteriormente; (h) cuando R1 y/o R2 no son H, eliminar el o los grupos protectores de hidroxi R1 y/o R2 del compuesto de estructura general VIa para generar calcipotriol. Reivindicacion 23: Un método de acuerdo con las reivindicaciones 1-22, en donde R1 y R2 representan alquilsililo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55396204P | 2004-03-18 | 2004-03-18 | |
| DKPA200400454 | 2004-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR048274A1 true AR048274A1 (es) | 2006-04-12 |
Family
ID=34961016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101046A AR048274A1 (es) | 2004-03-18 | 2005-03-17 | Sintesis estereoselectiva de analogos de vitamina d |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1730108B1 (es) |
| JP (1) | JP4667450B2 (es) |
| KR (1) | KR100859277B1 (es) |
| CN (1) | CN1934078B (es) |
| AR (1) | AR048274A1 (es) |
| AT (1) | ATE390411T1 (es) |
| BR (1) | BRPI0507318A (es) |
| CA (1) | CA2555260C (es) |
| CY (1) | CY1108156T1 (es) |
| DE (2) | DE602005005645T2 (es) |
| ES (1) | ES2304686T3 (es) |
| IL (1) | IL176718A (es) |
| PL (1) | PL1730108T3 (es) |
| RU (1) | RU2380359C2 (es) |
| SI (1) | SI1730108T1 (es) |
| TW (1) | TWI324063B (es) |
| WO (1) | WO2005087719A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4744507B2 (ja) * | 2004-04-02 | 2011-08-10 | レオ ファーマ アクティーゼルスカブ | ビタミンｄ類似体の合成に有用な中間体の新規製造法 |
| CN101400649B (zh) | 2006-03-17 | 2012-07-04 | 利奥制药有限公司 | 药物中间体的异构化 |
| US8013189B2 (en) | 2007-09-21 | 2011-09-06 | Basf Se | Accelerated amide and ester reductions with amine boranes and additives |
| EP2299809B1 (en) * | 2008-06-17 | 2018-10-17 | Ben Gurion University Of The Negev R&D Authority | Substituted cyclohexylidene-ethylidene-octahydro-indene compounds |
| CN103265528B (zh) * | 2013-05-10 | 2015-05-06 | 湖南千金湘江药业股份有限公司 | 埃索美拉唑镁的制备方法 |
| CN106908524B (zh) * | 2015-12-23 | 2021-05-04 | 重庆华邦胜凯制药有限公司 | 卡泊三醇中间体l及其潜在基因毒性杂质的分离与测定方法 |
| CN107643354B (zh) * | 2016-07-22 | 2022-02-01 | 重庆华邦胜凯制药有限公司 | 卡泊三醇起始原料a及相关杂质的分离与测定方法 |
| ES2945426B2 (es) * | 2021-12-30 | 2024-01-22 | Laboratorios Vinas S A | Procedimiento para obtener epímeros 24S a partir de derivados de vitaminas D y procedimiento de obtención de vitaminas D relacionado |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866048A (en) * | 1985-08-02 | 1989-09-12 | Leo Pharmaceutical Products Ltd. | Novel vitamin D analogues |
| JPH075542B2 (ja) * | 1988-09-14 | 1995-01-25 | 呉羽化学工業株式会社 | ビタミンｄ▲下３▼誘導体及びその製造方法 |
| US5247104A (en) * | 1992-11-04 | 1993-09-21 | Wisconsin Alumni Research Foundation | Preparation of 1α, 24-dihydroxyvitamin D analogs |
| GB9300763D0 (en) * | 1993-01-15 | 1993-03-03 | Leo Pharm Prod Ltd | Chemical compound |
| US5449668A (en) * | 1993-06-04 | 1995-09-12 | Duphar International Research B.V. | Vitamin D compounds and method of preparing these compounds |
| GB9524812D0 (en) * | 1995-12-05 | 1996-02-07 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9622590D0 (en) * | 1996-10-30 | 1997-01-08 | Leo Pharm Prod Ltd | Chemical compounds |
| US6262283B1 (en) * | 1996-12-06 | 2001-07-17 | Magainin Pharmaceuticals Inc. | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
| EP1123921A4 (en) * | 1998-10-23 | 2003-08-20 | Teijin Ltd | VITAMIN D 3 DERIVATIVES? AND MEDICINES FOR INFLAMMATORY RESPIRATORY DISEASES CONTAINING THEM |
-
2005
- 2005-03-10 CA CA2555260A patent/CA2555260C/en not_active Expired - Fee Related
- 2005-03-10 EP EP05706821A patent/EP1730108B1/en not_active Expired - Lifetime
- 2005-03-10 WO PCT/DK2005/000161 patent/WO2005087719A1/en not_active Ceased
- 2005-03-10 JP JP2007503195A patent/JP4667450B2/ja not_active Expired - Fee Related
- 2005-03-10 SI SI200530248T patent/SI1730108T1/sl unknown
- 2005-03-10 BR BRPI0507318-9A patent/BRPI0507318A/pt not_active IP Right Cessation
- 2005-03-10 DE DE602005005645T patent/DE602005005645T2/de not_active Expired - Lifetime
- 2005-03-10 ES ES05706821T patent/ES2304686T3/es not_active Expired - Lifetime
- 2005-03-10 KR KR1020067015590A patent/KR100859277B1/ko not_active Expired - Fee Related
- 2005-03-10 DE DE05706821T patent/DE05706821T1/de active Pending
- 2005-03-10 CN CN2005800086209A patent/CN1934078B/zh not_active Expired - Fee Related
- 2005-03-10 PL PL05706821T patent/PL1730108T3/pl unknown
- 2005-03-10 AT AT05706821T patent/ATE390411T1/de active
- 2005-03-10 RU RU2006129922/04A patent/RU2380359C2/ru active
- 2005-03-16 TW TW094108053A patent/TWI324063B/zh not_active IP Right Cessation
- 2005-03-17 AR ARP050101046A patent/AR048274A1/es unknown
-
2006
- 2006-07-05 IL IL176718A patent/IL176718A/en active IP Right Grant
-
2008
- 2008-06-26 CY CY20081100667T patent/CY1108156T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1108156T1 (el) | 2014-02-12 |
| ES2304686T3 (es) | 2008-10-16 |
| DE602005005645T2 (de) | 2009-06-18 |
| CA2555260A1 (en) | 2005-09-22 |
| CN1934078A (zh) | 2007-03-21 |
| KR100859277B1 (ko) | 2008-09-19 |
| EP1730108A1 (en) | 2006-12-13 |
| CN1934078B (zh) | 2011-07-06 |
| WO2005087719A1 (en) | 2005-09-22 |
| BRPI0507318A (pt) | 2007-06-26 |
| HK1098122A1 (en) | 2007-07-13 |
| JP2007529433A (ja) | 2007-10-25 |
| DE05706821T1 (de) | 2008-02-07 |
| KR20060134045A (ko) | 2006-12-27 |
| TWI324063B (en) | 2010-05-01 |
| IL176718A (en) | 2007-07-04 |
| ATE390411T1 (de) | 2008-04-15 |
| RU2006129922A (ru) | 2008-02-27 |
| TW200539866A (en) | 2005-12-16 |
| RU2380359C2 (ru) | 2010-01-27 |
| CA2555260C (en) | 2011-12-06 |
| EP1730108B1 (en) | 2008-03-26 |
| JP4667450B2 (ja) | 2011-04-13 |
| SI1730108T1 (sl) | 2008-08-31 |
| DE602005005645D1 (de) | 2008-05-08 |
| PL1730108T3 (pl) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066858A (es) | Inhibidores de gsk-3 | |
| ECSP066406A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| PA8676201A1 (es) | Metodos para sintetizar 3-cianoquinolinas sustituidad y sus intermediarios | |
| NI200500090A (es) | Compuestos de benzofurano, composiciones y metodos para tratamiento y profilafixis de infecciones virales de hepatitis c y enfermedades asociadas | |
| AR083483A2 (es) | Proceso para la preparacion del citalopram racemico y del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram | |
| UA87115C2 (ru) | Ацетоновый сольват диметоксидоцетаксела и способ его получения | |
| CY1118836T1 (el) | Αντι-ιϊκα φωσφονικα αναλογα | |
| AR048274A1 (es) | Sintesis estereoselectiva de analogos de vitamina d | |
| PE20220169A1 (es) | Compuestos macrociclicos como agonistas de sting | |
| AR109669A1 (es) | Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano | |
| AR069225A1 (es) | Procedimiento de preparacion de compuestos morfinicos | |
| BRPI0506655A (pt) | dehidrofenilahistinas e seus análogos, e sìntese de dehidrofenilahistinas e seus análogos | |
| BR0112848A (pt) | Processos para a preparação de ácido r-lipóico ou de ácido s-lipóico, de ácido r-dihidrolipóico ou de ácido s-dihidrolipóico puros, e de sais farmacologicamente aceitáveis ou de derivados de ácido r-lipóico ou de ácido s-lipóico, e, composto | |
| MY146099A (en) | Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues | |
| ATE374760T1 (de) | Verfahren zur herstellung von 4-fluor-1,3- dioxolan-2-on | |
| EP1623982A4 (en) | METHOD FOR PRODUCING DOCETAXEL TRIHYDRATE | |
| ES2531393T3 (es) | Proceso de semisíntesis para la preparación de 10 desacetil-N-desbenzoil-paclitaxel | |
| MY148301A (en) | Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds | |
| ATE256108T1 (de) | Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen | |
| AR048544A1 (es) | Procedimiento para la preparacion de melamina pura | |
| CO2024015540A2 (es) | Métodos de flujo continuo para producir manosa-1-fosfato, polimorfos de manosa-1-fosfato y composiciones y usos relacionados con los mismos | |
| UY29069A1 (es) | Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia | |
| AR111318A1 (es) | Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano | |
| WO2007038250A3 (en) | 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof | |
| AR083541A1 (es) | Derivado de 23-ino-vitamina d |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |